[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-363981-105":59,"doc-detail-363981-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","hemostatic-efficacy-and-clinical-outcomes-of-radiotherapy-in-older-adult-patients-with-advanced-bladder-cancer-and-hematuria-unsuitable-for-standard-treatment","Hemostatic Efficacy and Clinical Outcomes of Radiotherapy in Older Adult Patients With Advanced Bladder Cancer and Hematuria Unsuitable for Standard Treatment","","Older adult patients with advanced bladder cancer and hematuria are often unsuitable for surgery or systemic therapy and may experience persistent gross hematuria with severe urinary symptoms. This retrospective study evaluated radiotherapy in 49 such patients with pathologically confirmed urothelial carcinoma and persistent hemorrhagic hematuria. After cumulative doses of 10–40 Gy, bleeding reduction, symptom improvement, bladder irrigation discontinuation, and complete gross hematuria disappearance were observed. Median overall survival was 14 months, with acceptable adverse-event profiles and lower outcomes than radical-dose radiotherapy.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/hemostatic-efficacy-and-clinical-outcomes-of-radiotherapy-in-older-adult-patients-with-advanced-bladder-cancer-and-hematuria-unsuitable-for-standard-treatment/363981/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/hemostatic-efficacy-and-clinical-outcomes-of-radiotherapy-in-older-adult-patients-with-advanced-bladder-cancer-and-hematuria-unsuitable-for-standard-treatment/363981.png","ImageObject",300,407,{"name":92,"@type":93},"nayy☆","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-01","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":52},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"Why were older adult patients with advanced bladder cancer included in this radiotherapy study?","Question",{"text":112,"@type":113},"They often cannot undergo surgery or systemic therapy due to frailty and comorbidities, and they may present with persistent gross hematuria and severe urinary symptoms.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"What were the key outcomes used to evaluate radiotherapy?",{"text":117,"@type":113},"The study assessed hemostatic efficacy, overall survival, and adverse events.",{"name":119,"@type":110,"acceptedAnswer":120},"How quickly did bleeding and urinary symptoms improve after radiotherapy?",{"text":121,"@type":113},"Bleeding decreased after 5 fractions totaling 10 Gy, urinary irritation improved or resolved after 10 fractions totaling 20 Gy, and gross hematuria disappeared in all patients after 15 fractions totaling 30 Gy.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},363981,1790643936,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":52,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":41,"preview_page_count":19,"preview_urls":145},962090893153,"https://ap-avatar.wpscdn.com/davatar_9964176cb1d06d4a9deccf72a44ae3dc","CLINICAL RESEARCH  \ne-ISSN 1643-3750  \n© Med Sci Monit, 2026; 32: e953113 DOI: 10. 12659/MSM.953113  \nReceived: 2026.02.11  \nAccepted: 2026.05.27  \nAvailable online: 2026.06.07  \nPublished: 2026.08.08  \nAuthors’ Contribution: Study Design A  \nData Collection B Statistical Analysis C Data Interpretation D Manuscript Preparation E Literature Search F Funds Collection G  \nABCDEF 1  \nABCDEF 1  \nABCDEF 1  \nABCD 1 BCD 1  \nBCF 1  \nBCF 1  \nBC 1  \nCF 1  \nAG 1  \nABCEFG 1,2  \nCorresponding Authors:  \nFinancial support:  \nConflict of interest:  \nHemostatic Efficacy and Clinical Outcomes of Radiotherapy in Older Adult Patients With Advanced Bladder Cancer and Hematuria Unsuitable for Standard Treatment  \nJudi Xu*  \nYing Huang* Guoying Ni Yan Huang  \nQian Huang Hongxiang Liang Yufeng Ni  \nHaijing Xie Zhuangzhuang Yue Zhiyong Yang Hedai Liu  \n1 Department of Oncology, Chongming Hospital Affiliated with Shanghai University of Medicine and Health Sciences, Shanghai, PR China  \n2 Dingxi Cancer Institute of Traditional Chinese and Western Medicine, Dingxi, Gansu, PR China  \n* Judi Xu and Ying Huang contributed equally to this work  \nZhiyong Yang, e-mail: [yzy056006@163.com](yzy056006@163.com); Hedai Liu, e-mail: [liuhedai@aliyun.com](liuhedai@aliyun.com)  \nThis study was supported by the Shanghai Municipal Health Commission (grant No. 201940274) and the Key Discipline Program of the Chongming District Health Commission  \nNone declared  \nBackground: Older adult patients with advanced bladder cancer and frailty or comorbidities are often unsuitable for surgery or systemic therapy and may present with persistent gross hematuria and severe urinary symptoms. This study evaluated the hemostatic efficacy and clinical value of radiotherapy in this population.  \nMaterial/Methods: This retrospective study included 49 older adult patients with advanced bladder cancer and hemorrhagic hematuria, with a mean age of 78.3 ± 6.4 years. All patients had pathologically confirmed urothelial carcinoma of the bladder and persistent hematuria and were unsuitable for surgery or chemotherapy. After thorough communication and written informed consent, radiotherapy was administered. Outcomes included hemostatic efficacy, overall survival, and adverse events.  \nResults: Bleeding decreased after 5 fractions of radiotherapy with a cumulative dose of 10 Gy. After 10 fractions and  \n20 Gy, urinary irritation symptoms improved or resolved, and bladder irrigation was discontinued. After 15 fractions and 30 Gy, gross hematuria disappeared in all patients, with a hemostatic response rate of 100%. After  \n4 weeks and 40 Gy, patients were re-evaluated; 40 continued dose escalation, including 13 who discontinued at 52 to 56 Gy and 27 who completed 62 to 72 Gy. At follow-up, 24 patients had died and 25 remained alive. Median overall survival was 14 months. Exploratory univariate analysis showed different overall survival between radical-dose and palliative-dose radiotherapy.  \nConclusions: Radiotherapy was associated with effective hematuria control, urinary symptom relief, and acceptable clinical value in older adult patients with advanced bladder cancer. Larger controlled studies are needed to validate these findings.  \nKeywords: Bladder Neoplasms • Hematuria • Oncology • Prognosis • Radiotherapy  \nFull-text PDF: [https://www.medscimonit.com/abstract/index/idArt/953113](https://www.medscimonit.com/abstract/index/idArt/953113)  \n5078  3  2  28  \nPublisher’s note: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher  \nThis work is licensed under Creative Commons AttributionNonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)  \ne953113-1  \nIndexed in: [Current Contents/Clinical Medicine]","cbCaiaSLUEoieYMG","https://ap.wps.com/l/cbCaiaSLUEoieYMG","pdf",1064376,12,"English","# Introduction\n# Material/Methods\n# Results\n# Conclusions","[{\"question\":\"Why were older adult patients with advanced bladder cancer included in this radiotherapy study?\",\"answer\":\"They often cannot undergo surgery or systemic therapy due to frailty and comorbidities, and they may present with persistent gross hematuria and severe urinary symptoms.\"},{\"question\":\"What were the key outcomes used to evaluate radiotherapy?\",\"answer\":\"The study assessed hemostatic efficacy, overall survival, and adverse events.\"},{\"question\":\"How quickly did bleeding and urinary symptoms improve after radiotherapy?\",\"answer\":\"Bleeding decreased after 5 fractions totaling 10 Gy, urinary irritation improved or resolved after 10 fractions totaling 20 Gy, and gross hematuria disappeared in all patients after 15 fractions totaling 30 Gy.\"}]","Hemostatic Efficacy and Clinical Outcomes of Radiotherapy in Older Adult Patients With Advanced Bladder Cancer and Hematuria Unsuitable for Standard Treatment | PDF",1790154759,[146,150,154,158],{"page_no":8,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/4bfcc8833bb7326aab44e16089ab277e.webp",983,1376,{"page_no":14,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/7979e30ee9d27dbf5d6e643eea4990a5.webp",982,1374,{"page_no":81,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/45184f7dfaf8fc1b943a6569807d716f.webp",981,1373,{"page_no":19,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/064fb4036debf6dd410c42119864d247.webp",980,1372]